Jinyi Zhen

Ms. Jinyi Zhen


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2026 in Biology
Verified
Journal Article
Open access
PDF file
JZJinyi Zhen
Jinyi Zhen
ZZZhou Zhengrong
Zhou Zhengrong
RZRuiqi Zhu
Ruiqi Zhu
MKMeiqian Kuang
Meiqian Kuang
PHPan Huang
Pan Huang
Irritable bowel syndrome (IBS) is a multifactorial functional intestinal disorder whose pathogenesis involves intestinal microbiota imbalance, mucosal barrier impairment, immune–inflammatory responses, and dysregulation of the gut–brain axis. Lactobacillus reuteri has been shown to modulate the gut microbiota, produce antimicrobial metabolites, strengthen the intestinal mucosal barrier, suppress inflammatory responses, and participate in gut–brain axis regulation, thereby potentially contributing to the maintenance of intestinal homeostasis and the alleviation of IBS-related symptoms. These findings indicate that L. reuteri holds potential therapeutic value in the prevention and treatment of IBS. However, the majority of supporting evidence derives from animal experiments, in vitro studies, or indirect sources, and its precise mechanisms of action and clinical efficacy warrant further investigation.